Norges Bank Cure Vac N.V. Transaction History

Norges Bank

$716 Trillion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.31 - $4.99 $256,257 - $553,560	110,934 New	110,934 $377,000
Q4 2023 Feb 09, 2024	BUY	$3.96 - $6.41 $1.22 Million - $1.98 Million	308,675 New	308,675 $1.3 Million
Q3 2023 Nov 13, 2024	BUY	$6.5 - $10.77 $2.48 Million - $4.11 Million	381,846 New	381,846 $2.61 Million
Q3 2023 Nov 13, 2023	SELL	$6.5 - $10.77 $3.19 Million - $5.29 Million	-490,898 Closed	0 $0
Q2 2023 Aug 14, 2024	BUY	$6.69 - $12.25 $2.03 Million - $3.71 Million	302,802 Added 272.96%	413,736 $4.31 Million
Q2 2023 Aug 14, 2023	SELL	$6.69 - $12.25 $3.73 Million - $6.83 Million	-557,868 Closed	0 $0
Q1 2023 May 15, 2024	BUY	$6.38 - $12.5 $10.3 Million - $20.2 Million	1,613,736 New	1,613,736 $11.2 Million
Q4 2022 Feb 14, 2023	BUY	$5.75 - $8.5 $2.82 Million - $4.17 Million	490,898 New	490,898 $2.96 Million
Q3 2022 Nov 13, 2023	BUY	$7.48 - $15.24 $3.67 Million - $7.48 Million	490,898 New	490,898 $3.87 Million
Q2 2022 Aug 14, 2023	BUY	$13.18 - $19.41 $7.35 Million - $10.8 Million	557,868 New	557,868 $7.59 Million
Q1 2022 May 12, 2023	BUY	$14.73 - $35.25 $224,838 - $538,056	15,264 Added 3.11%	506,162 $9.93 Million
Q1 2022 May 09, 2022	SELL	$14.73 - $35.25 $6.97 Million - $16.7 Million	-472,962 Closed	0 $0
Q4 2021 Mar 09, 2022	BUY	$33.72 - $48.22 $15.9 Million - $22.8 Million	472,962 New	472,962 $16.2 Million
Q3 2021 Nov 14, 2022	BUY	$49.26 - $74.5 $18.1 Million - $27.4 Million	368,406 New	368,406 $20.1 Million
Q3 2021 Nov 05, 2021	SELL	$49.26 - $74.5 $16.1 Million - $24.4 Million	-327,444 Closed	0 $0
Q2 2021 Aug 15, 2022	BUY	$56.91 - $127.53 $18.6 Million - $41.8 Million	327,444 New	327,444 $24.1 Million
Q2 2021 Aug 10, 2021	SELL	$56.91 - $127.53 $27.9 Million - $62.6 Million	-490,788 Closed	0 $0
Q1 2021 May 09, 2022	BUY	$79.79 - $126.29 $39.2 Million - $62 Million	490,788 New	490,788 $44.9 Million

Others Institutions Holding CVAC

# of Institutions

Shares Held

12.2M

Call Options Held

164K

Put Options Held

117K

Israel Englander Millennium Management LLC | New York, Ny

2.42M
Shares

$9.02 Million
0.0% of portfolio
Black Rock Inc. New York, NY

2.25M
Shares

$8.41 Million
0.0% of portfolio
Bill & Melinda Gates Foundation Seattle, WA

1.57M
Shares

$5.85 Million
10.6% of portfolio
Ken Griffin Citadel Advisors LLC | Chicago, Il

1.01M
Shares

$3.77 Million
0.0% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

780K
Shares

$2.91 Million
0.01% of portfolio

View Full List

About CureVac N.V.

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $699M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

More about CVAC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

News

Stay updated on Norges Bank with notifications on news.

Account